Antidepressants for Anxiety: What Works, What Doesn't, and What to Expect

If you're dealing with anxiety, not depression, it's fair to wonder why a clinician would hand you an "antidepressant."

The short answer: the labels are a quirk of history, not biology. SSRIs and SNRIs were first developed for depression, but the same serotonin and norepinephrine systems they act on are central to anxiety - and for most anxiety disorders these medications outperform the benzodiazepines that patients often expect. This is what the research supports, what each option does, and what to realistically expect when you start.

Why "antidepressants" treat anxiety

Anxiety disorders and depression share overlapping circuitry, particularly serotonin and norepinephrine signaling across the amygdala, prefrontal cortex, and hippocampus - the systems that govern the fear response described in the diagnostic framework clinicians use (DSM-5-TR). SSRIs and SNRIs block the reuptake of these neurotransmitters, raising their availability in the synapse over time.

After 4 to 8 weeks of consistent use, the effect is a quieting of the over-reactive fear response that defines anxiety disorders. The brain becomes less likely to read ambiguous situations as threats, less prone to catastrophic predictions, and more able to sit with uncertainty.

These medications don't sedate you or blunt your emotions at therapeutic doses, they don't create physical dependence, and they work around the clock - not only when a panic attack is building.

First-line options: SSRIs

SSRIs are the first choice for most anxiety disorders, backed by decades of randomized trials. A 2019 Lancet network meta-analysis pooling 89 trials and 25,441 participants found several agents effective for generalized anxiety disorder, with good tolerability (Slee et al., 2019). The most studied options for anxiety include:

Sertraline (Zoloft)

Sertraline is among the most prescribed psychiatric medications in the world, with strong evidence across generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, PTSD, and OCD. It has a relatively favorable side effect profile, is available generically at low cost, and has minimal drug interactions compared with older SSRIs. A typical starting dose is 25-50 mg daily, titrated to 100-200 mg based on response, with most patients finding an effective dose within 6-12 weeks.

Escitalopram (Lexapro)

Escitalopram is one of the most selective SSRIs, which usually means fewer side effects than less selective agents. It is FDA-approved for both GAD and major depressive disorder, and many clinicians consider it the cleanest SSRI for tolerability - particularly for people who have struggled with side effects on other agents. Starting dose is typically 5-10 mg, target range 10-20 mg.

Fluoxetine (Prozac)

Fluoxetine has the longest half-life of any SSRI (weeks, not days), so missed doses matter less and discontinuation is smoother. It is FDA-approved for panic disorder, OCD, and depression. Its activating quality can worsen anxiety early on, so starting at 10 mg rather than 20 mg is generally advisable.

Paroxetine (Paxil)

Paroxetine has broad FDA approval across anxiety disorders but is prescribed less often for new starts because of a heavier side effect burden (weight gain, sexual dysfunction, sedation) and a difficult discontinuation profile. It remains a reasonable choice for people who have responded well to it before.

Second-line options: SNRIs

SNRIs add norepinephrine reuptake inhibition to serotonin, which can help people with prominent physical anxiety symptoms - fatigue, pain, trouble concentrating. In the 2019 Lancet analysis, venlafaxine was among the agents with the most convincing evidence for GAD (Slee et al., 2019).

Venlafaxine ER (Effexor XR)

Venlafaxine is FDA-approved for GAD, social anxiety disorder, and panic disorder, and is well studied and broadly effective. The main cautions are a somewhat difficult discontinuation process and dose-dependent blood pressure elevation at higher doses. Starting at 37.5 mg and titrating slowly reduces early side effects.

Duloxetine (Cymbalta)

Duloxetine is FDA-approved for GAD and is useful when anxiety co-occurs with chronic pain (fibromyalgia, neuropathic pain). It tends to be activating, which helps fatigue but can worsen sleep early on. Like venlafaxine, it needs gradual tapering to stop.

What about benzodiazepines?

Benzodiazepines - alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), diazepam (Valium) - work fast, often within 30 to 60 minutes, which makes them feel immediately useful in a way SSRIs don't.

For most people with an anxiety disorder, though, they aren't the right long-term answer. In 2020 the FDA required an updated boxed warning - its most prominent - across the entire benzodiazepine class, describing the risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions that can include life-threatening seizures (FDA, 2020). Beyond that:

• Tolerance develops, so the calming effect fades and doses creep up over time.
• Physical dependence can set in within days to weeks, even when taken as prescribed.
• They treat the symptom in the moment without changing the neural pathways that generate the anxiety.
• In older adults they impair memory and raise fall risk.
• Used to escape an anxious situation, they undercut the habituation that exposure-based therapy relies on.

Benzodiazepines do have a place - acute panic, procedural anxiety, a short bridge while an SSRI takes effect. But major evidence-based guidelines do not recommend them as standalone, ongoing treatment for anxiety disorders.

Buspirone: an underused option

Buspirone is a non-benzodiazepine anxiolytic FDA-approved specifically for GAD. It isn't sedating, doesn't cause physical dependence, and has no abuse potential - a good fit for people who need something other than an SSRI/SNRI, or whose history makes benzodiazepines inappropriate. Its limits: it takes 2 to 4 weeks to work (people used to a benzodiazepine's instant effect often quit it too soon), it doesn't help panic disorder much, and it's dosed twice daily. For GAD specifically, it's consistently underused relative to its evidence.

Hydroxyzine: useful for acute anxiety

Hydroxyzine (Vistaril, Atarax) is an antihistamine with anxiolytic properties. It works within 30 to 60 minutes, is non-habit-forming, and doesn't impair thinking at low doses, which makes it a reasonable as-needed option - the "something for when I need it" many people want, without the dependence risk of benzodiazepines. It is sedating, which limits daytime use but helps anxiety-related insomnia. Doses of 25-50 mg as needed are typical.

What to expect when you start

This is where people give up too early. SSRIs and SNRIs don't work right away - they need consistent daily dosing for 4 to 8 weeks before the full anti-anxiety effect shows up.

The first week or two can actually feel worse with the more activating agents. More jitteriness, nervousness, and disrupted sleep are common early on. That's a known pharmacological effect, not a sign the medication is wrong for you, and starting low and going slow blunts it. A reasonable timeline:

• Weeks 1-2: possible bump in anxiety, sleep changes, and GI effects (nausea, loose stools). Taking the dose with food helps; these usually settle.
• Weeks 3-4: side effects typically ease; some people notice steadier sleep or less background anxiety.
• Weeks 6-8: full effect usually apparent. A partial response may warrant a dose increase.
• Week 12+: no meaningful improvement after an adequate dose and duration is a signal to switch or augment.

Common side effects and how to manage them

Sexual dysfunction

This is the most commonly reported long-term effect of SSRIs. It's usually manageable - through dose reduction, switching to or adding bupropion (which has a favorable profile here), or targeted treatment for specific concerns.

Weight gain

Modest weight change can occur with long-term use in some people. Paroxetine has the highest association; sertraline and escitalopram are among the more weight-neutral.

Discontinuation symptoms

Stopping an SSRI or SNRI abruptly - paroxetine and venlafaxine especially - can cause flu-like feelings, sensory disturbances ("brain zaps"), and rebound anxiety. In a 2024 Lancet Psychiatry meta-analysis, when you separate out the effect of stopping the drug itself from nocebo effects, roughly one in six to seven people had discontinuation symptoms attributable to the medication, and about one in 35 had severe symptoms (Henssler et al., 2024). This is not addiction - it's a discontinuation effect, and a gradual taper under provider guidance prevents most of it.

The role of therapy alongside medication

Medication and therapy aren't competitors - they work through different mechanisms, and for moderate to severe anxiety the combination tends to do better than either alone. Cognitive-behavioral therapy, especially exposure-based work for panic, social anxiety, and OCD, targets the behaviors and thought patterns that keep anxiety going. Medication lowers the intensity of the anxiety response, which makes that exposure work more doable. Together they produce more durable relief than medication by itself often does. At Elite Mind Wellness, medication management includes therapist-referral coordination for people who are appropriate candidates for combined treatment.

When to seek help

If anxiety is interfering with your work, your relationships, your sleep, or the things you want to do, effective treatment exists - a proper evaluation, the right medication at the right dose, and targeted therapy resolve or substantially reduce symptoms for most people. Mild, situational anxiety sometimes settles on its own; anxiety that has been present for months or years usually doesn't.

Elite Mind Wellness provides telehealth psychiatric care for adults seeking evidence-based treatment for anxiety. If you're in crisis right now or thinking about harming yourself, please don't wait for an appointment - call or text 988, the Suicide & Crisis Lifeline, any time.

Book your first evaluation.

If any of this sounds familiar, you don't have to sort it out alone - book your first evaluation and we'll take it from there.